INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $421,000 | -45.9% | 80,000 | -19.2% | 0.14% | -66.7% |
| Q4 2015 | $778,000 | -58.2% | 99,000 | -55.1% | 0.42% | -51.8% |
| Q3 2015 | $1,863,000 | -51.5% | 220,618 | -37.1% | 0.87% | -29.6% |
| Q2 2015 | $3,841,000 | -43.1% | 350,604 | -27.5% | 1.24% | -23.7% |
| Q1 2015 | $6,754,000 | -2.4% | 483,262 | +18.0% | 1.63% | -10.5% |
| Q4 2014 | $6,922,000 | +57.7% | 409,715 | +25.4% | 1.82% | +16.4% |
| Q3 2014 | $4,388,000 | +187.2% | 326,821 | +172.4% | 1.56% | -11.5% |
| Q2 2014 | $1,528,000 | +7.1% | 120,000 | 0.0% | 1.77% | +29.1% |
| Q1 2014 | $1,427,000 | – | 120,000 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |